Scolr Pharma, Inc.

Wyeth Consumer Healthcare licenses CDT drug delivery platform for potential OTC formulation

Published in Law and Health Weekly, January 21st, 2006

Scolr Pharma, Inc. (DDD) announced that it has executed a licensing agreement with Wyeth Consumer Healthcare, a division of Wyeth (WYE), granting the worldwide rights to utilize Scolr Pharma's proprietary and patented CDT drug delivery platform for the potential use in an over-the-counter (OTC) formulation.

There is currently no formulation of this type approved for use in North America.

Under the terms of this agreement, Wyeth Consumer Healthcare will pay Scolr Pharma an upfront licensing fee, and will make milestone and royalty payments. The license agreement also contemplates further arrangements between Scolr Pharma and Wyeth Consumer Healthcare...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2006-01-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry